SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Adeshwar Meditex informs about outcome of board meeting

29 Oct 2021 Evaluate

Adeshwar Meditex has informed that as decided in the Meeting of the Board of Directors of the Company held today, i.e., Friday, October 29, 2021, at 02.00 pm, the board has approved and taken on record the Un-audited Financial Results along with Limited Review Report in compliance with Accounting Standards (AS) for the half year ended on September 30, 2021. The said copy of Un-audited Financial Results for the half year ended September 30, 2021 is enclosed in pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting commenced at 02:00 pm (IST) and concluded at 2.55 pm (IST).

The above information is a part of company’s filings submitted to BSE.

Adeshwar Meditex Share Price

18.41 0.00 (0.00%)
27-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1783.55
Dr. Reddys Lab 1277.80
Cipla 1400.70
Zydus Lifesciences 1088.90
Lupin 2268.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×